|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80186-5-O |
K562 (Erythroleukemia Cells) (cluster #5 Of 11), Other |
Other |
96 |
0.49 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
120 |
0.48 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.08 |
6.67 |
-12.94 |
1 |
4 |
0 |
60 |
268.268 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.66 |
13.46 |
-5.43 |
0 |
0 |
0 |
0 |
280.37 |
2 |
↓
|
|
|
Analogs
-
560899
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.17 |
-0.05 |
-10.56 |
1 |
4 |
0 |
51 |
281.311 |
3 |
↓
|
|
|
Analogs
-
22056448
-
-
22056453
-
-
31474612
-
-
1552220
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 54 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CAC1C-1-E |
Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
38 |
0.31 |
Binding ≤ 10μM
|
CAC1D-2-E |
Voltage-gated L-type Calcium Channel Alpha-1D Subunit (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
38 |
0.31 |
Binding ≤ 10μM
|
CAC1S-1-E |
Voltage-gated L-type Calcium Channel Alpha-1S Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
58 |
0.31 |
Binding ≤ 10μM
|
KCNH2-5-E |
HERG (cluster #5 Of 5), Eukaryotic |
Eukaryotes |
6850 |
0.22 |
Binding ≤ 10μM
|
MDR1-1-E |
P-glycoprotein 1 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9800 |
0.21 |
Binding ≤ 10μM
|
MRP1-1-E |
Multidrug Resistance-associated Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9660 |
0.21 |
Binding ≤ 10μM
|
P97706-1-E |
Sodium Channel Protein Type VI Alpha Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2500 |
0.24 |
Binding ≤ 10μM
|
S22A1-1-E |
Solute Carrier Family 22 Member 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6800 |
0.22 |
Binding ≤ 10μM
|
SCN1A-1-E |
Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3300 |
0.23 |
Binding ≤ 10μM
|
SCN2A-1-E |
Sodium Channel Protein Type II Alpha Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3300 |
0.23 |
Binding ≤ 10μM
|
SCN3A-1-E |
Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3300 |
0.23 |
Binding ≤ 10μM
|
SCN5A-1-E |
Sodium Channel Protein Type V Alpha Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2500 |
0.24 |
Binding ≤ 10μM
|
SCN8A-1-E |
Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3300 |
0.23 |
Binding ≤ 10μM
|
TSPO-1-E |
Peripheral-type Benzodiazepine Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.38 |
Binding ≤ 10μM
|
CAC1C-1-E |
Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
38 |
0.31 |
Functional ≤ 10μM
|
CAC1D-1-E |
Voltage-gated L-type Calcium Channel Alpha-1D Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
38 |
0.31 |
Functional ≤ 10μM
|
KCNH2-1-E |
HERG (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
143 |
0.29 |
Functional ≤ 10μM
|
MDR1-1-E |
P-glycoprotein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6300 |
0.22 |
Functional ≤ 10μM
|
MDR3-1-E |
P-glycoprotein 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10000 |
0.21 |
Functional ≤ 10μM
|
P97706-1-E |
Sodium Channel Protein Type VI Alpha Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2500 |
0.24 |
Functional ≤ 10μM
|
SCN5A-1-E |
Sodium Channel Protein Type V Alpha Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2500 |
0.24 |
Functional ≤ 10μM
|
CP3A4-2-E |
Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
6460 |
0.22 |
ADME/T ≤ 10μM
|
Z50425-11-O |
Plasmodium Falciparum (cluster #11 Of 22), Other |
Other |
800 |
0.26 |
Functional ≤ 10μM
|
Z50425-11-O |
Plasmodium Falciparum (cluster #11 Of 22), Other |
Other |
3162 |
0.23 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
800 |
0.26 |
Functional ≤ 10μM
|
Z50592-3-O |
Oryctolagus Cuniculus (cluster #3 Of 8), Other |
Other |
300 |
0.28 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
47 |
0.31 |
Functional ≤ 10μM
|
Z80133-1-O |
EMT6 (Mammary Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
5800 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
53 |
0.31 |
Functional ≤ 10μM
|
Z80232-1-O |
MCF7-VP (cluster #1 Of 1), Other |
Other |
12 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
3100 |
0.23 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM
|
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.35 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM
|
Z80773-1-O |
CHRC/5 Cell Line (cluster #1 Of 1), Other |
Other |
3000 |
0.23 |
Functional ≤ 10μM
|
Z80774-1-O |
CHRC5 Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.25 |
Functional ≤ 10μM |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
500 |
0.27 |
Functional ≤ 10μM
|
Z81008-1-O |
Human Breast Cancer Cell Lines (cluster #1 Of 1), Other |
Other |
2400 |
0.24 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
700 |
0.26 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.55 |
12.51 |
-58.32 |
1 |
6 |
1 |
65 |
455.619 |
13 |
↓
|
Hi
High (pH 8-9.5)
|
4.55 |
10.19 |
-15.26 |
0 |
6 |
0 |
64 |
454.611 |
13 |
↓
|
|
|
Analogs
-
4100773
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 6 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
5200 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.30 |
2.88 |
-13.85 |
0 |
3 |
0 |
35 |
302.757 |
5 |
↓
|
|
|
Analogs
-
4329693
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
760 |
0.31 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.79 |
-3.03 |
-8.72 |
2 |
8 |
0 |
84 |
378.436 |
6 |
↓
|
|
|
Analogs
-
27643230
-
-
4329679
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
920 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.38 |
-2.31 |
-10.44 |
2 |
9 |
0 |
94 |
408.462 |
7 |
↓
|
|
|
Analogs
-
1705668
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
3000 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.24 |
7.11 |
-7.67 |
0 |
5 |
0 |
62 |
300.31 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 4 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.37 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.37 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
400 |
0.39 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
400 |
0.39 |
Functional ≤ 10μM
|
Z80099-3-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
4860 |
0.32 |
Functional ≤ 10μM
|
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
83 |
0.43 |
Functional ≤ 10μM
|
Z80125-9-O |
DU-145 (Prostate Carcinoma) (cluster #9 Of 9), Other |
Other |
34 |
0.45 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
31 |
0.46 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
560 |
0.38 |
Functional ≤ 10μM
|
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
41 |
0.45 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
437 |
0.39 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
394 |
0.39 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z80555-1-O |
TSGH (cluster #1 Of 1), Other |
Other |
170 |
0.41 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
300 |
0.40 |
Functional ≤ 10μM
|
Z80798-1-O |
CPT30 Cell Line (cluster #1 Of 1), Other |
Other |
37 |
0.45 |
Functional ≤ 10μM
|
Z80900-1-O |
HA22T Cell Line (cluster #1 Of 1), Other |
Other |
3706 |
0.33 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
33 |
0.46 |
Functional ≤ 10μM
|
Z80967-2-O |
Hone-1 Cell Line (cluster #2 Of 2), Other |
Other |
87 |
0.43 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
35 |
0.45 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
30 |
0.46 |
Functional ≤ 10μM
|
Z81252-7-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #7 Of 11), Other |
Other |
28 |
0.46 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.36 |
4.04 |
-11.69 |
1 |
6 |
0 |
74 |
318.325 |
6 |
↓
|
|
|
|
|
Analogs
-
4098705
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 39 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.01 |
1.74 |
-10.81 |
3 |
5 |
0 |
95 |
270.24 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
3.01 |
2.52 |
-45.75 |
2 |
5 |
-1 |
98 |
269.232 |
0 |
↓
|
|
|
Analogs
-
3225
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 11 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AHR-1-E |
Aryl Hydrocarbon Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.57 |
Binding ≤ 10μM
|
ESR1-1-E |
Estrogen Receptor Alpha (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
261 |
0.46 |
Binding ≤ 10μM
|
ABL1-2-E |
Tyrosine-protein Kinase ABL (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
10000 |
0.35 |
Functional ≤ 10μM
|
BCR-2-E |
Breakpoint Cluster Region Protein (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
10000 |
0.35 |
Functional ≤ 10μM
|
MDR1-1-E |
P-glycoprotein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8000 |
0.36 |
Functional ≤ 10μM
|
CP1A1-1-E |
Cytochrome P450 1A1 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
830 |
0.43 |
ADME/T ≤ 10μM
|
CP1A2-3-E |
Cytochrome P450 1A2 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
6200 |
0.36 |
ADME/T ≤ 10μM
|
CP1B1-1-E |
Cytochrome P450 1B1 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
790 |
0.43 |
ADME/T ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
4000 |
0.38 |
Functional ≤ 10μM
|
Z80186-2-O |
K562 (Erythroleukemia Cells) (cluster #2 Of 11), Other |
Other |
10000 |
0.35 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
1100 |
0.42 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
5700 |
0.37 |
Functional ≤ 10μM
|
Z81252-7-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #7 Of 11), Other |
Other |
1200 |
0.41 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.59 |
7.25 |
-7.23 |
0 |
3 |
0 |
28 |
270.328 |
5 |
↓
|
|
|
Analogs
-
899213
-
-
13456778
-
-
3225
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 4 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AHR-1-E |
Aryl Hydrocarbon Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
75 |
0.50 |
Binding ≤ 10μM
|
ESR1-1-E |
Estrogen Receptor Alpha (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
132 |
0.48 |
Binding ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1800 |
0.40 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1800 |
0.40 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3500 |
0.38 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1800 |
0.40 |
Functional ≤ 10μM
|
TBB3-3-E |
Tubulin Beta-3 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
3500 |
0.38 |
Functional ≤ 10μM
|
TBB4A-3-E |
Tubulin Beta-4 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
3500 |
0.38 |
Functional ≤ 10μM
|
TBB4B-3-E |
Tubulin Beta-2 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
3500 |
0.38 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.38 |
Functional ≤ 10μM
|
TBB8-3-E |
Tubulin Beta-8 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
3500 |
0.38 |
Functional ≤ 10μM
|
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
3800 |
0.38 |
Functional ≤ 10μM
|
Z80054-4-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
80 |
0.50 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
240 |
0.46 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
54 |
0.51 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
120 |
0.48 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
218 |
0.47 |
Functional ≤ 10μM
|
Z80526-2-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #2 Of 6), Other |
Other |
300 |
0.46 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
220 |
0.47 |
Functional ≤ 10μM
|
Z81001-1-O |
TSGH 9201 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
324 |
0.45 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
253 |
0.46 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
280 |
0.46 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.59 |
2.19 |
-7.53 |
0 |
3 |
0 |
27 |
270.328 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4000 |
0.33 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4000 |
0.33 |
Binding ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.37 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.37 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
300 |
0.40 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
300 |
0.40 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.37 |
Functional ≤ 10μM
|
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
1000 |
0.37 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
12 |
0.48 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80555-1-O |
TSGH (cluster #1 Of 1), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80792-1-O |
Colon 26 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
269 |
0.40 |
Functional ≤ 10μM
|
Z81001-1-O |
TSGH 9201 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
1 |
0.55 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
45 |
0.45 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
45 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.60 |
1.02 |
-9.26 |
2 |
5 |
0 |
62 |
315.369 |
6 |
↓
|
|
|
Analogs
-
6117135
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 29 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AL1A7-1-E |
Aldehyde Dehydrogenase, Cytosolic 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6000 |
0.37 |
Binding ≤ 10μM |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
8700 |
0.35 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
10000 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.42 |
1.23 |
-12.42 |
3 |
5 |
0 |
95 |
270.24 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4140 |
0.50 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
4000 |
0.50 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.64 |
8 |
-11.83 |
0 |
2 |
0 |
34 |
200.237 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
D3ZWV0-1-E |
Retinoic Acid Receptor Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.35 |
Binding ≤ 10μM
|
Q499N1-1-E |
Retinoic Acid Receptor Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.33 |
Binding ≤ 10μM
|
RARA-1-E |
Retinoic Acid Receptor Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.33 |
Binding ≤ 10μM
|
RARB-1-E |
Retinoic Acid Receptor Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
200 |
0.33 |
Binding ≤ 10μM
|
RARG-1-E |
Retinoic Acid Receptor Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
100 |
0.35 |
Binding ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
100 |
0.35 |
Functional ≤ 10μM
|
Z80140-1-O |
GBM (cluster #1 Of 1), Other |
Other |
180 |
0.34 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
150 |
0.34 |
Functional ≤ 10μM
|
Z80250-1-O |
Me665/2/21 (cluster #1 Of 1), Other |
Other |
250 |
0.33 |
Functional ≤ 10μM
|
Z80306-1-O |
NB-4 (Promyelocytic Leukemia Cells) (cluster #1 Of 1), Other |
Other |
82 |
0.35 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
210 |
0.33 |
Functional ≤ 10μM
|
Z80449-1-O |
SAOS-2 (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
250 |
0.33 |
Functional ≤ 10μM
|
Z80561-1-O |
U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
260 |
0.33 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
250 |
0.33 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
320 |
0.32 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
190 |
0.34 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
100 |
0.35 |
Functional ≤ 10μM
|
Z81065-3-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
230 |
0.33 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
120 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.53 |
0.19 |
-51.44 |
1 |
3 |
-1 |
60 |
373.472 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
810 |
0.37 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
1200 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.66 |
9.93 |
-9.38 |
0 |
3 |
0 |
30 |
305.377 |
4 |
↓
|
|
|
Analogs
-
8410363
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 6 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TBA1A-2-E |
Tubulin Alpha-3 Chain (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
5000 |
0.39 |
Binding ≤ 10μM
|
Z80491-1-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #1 Of 4), Other |
Other |
1390 |
0.43 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
2530 |
0.41 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.47 |
7.82 |
-9.66 |
1 |
3 |
0 |
46 |
248.285 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
3.93 |
6.74 |
-46.16 |
0 |
3 |
-1 |
49 |
247.277 |
2 |
↓
|
|
|
Analogs
-
1591265
-
-
1591410
-
-
1611146
-
-
1612318
-
-
1616881
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1300 |
0.37 |
Binding ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1300 |
0.37 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
200 |
0.43 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1300 |
0.37 |
Binding ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.36 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.36 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1300 |
0.37 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.36 |
Functional ≤ 10μM
|
TBB3-3-E |
Tubulin Beta-3 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Functional ≤ 10μM
|
TBB4A-3-E |
Tubulin Beta-4 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Functional ≤ 10μM
|
TBB4B-3-E |
Tubulin Beta-2 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Functional ≤ 10μM
|
TBB8-3-E |
Tubulin Beta-8 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Functional ≤ 10μM
|
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
2500 |
0.36 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
13 |
0.50 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
15 |
0.50 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
17 |
0.49 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
20 |
0.49 |
Functional ≤ 10μM
|
Z81001-1-O |
TSGH 9201 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
20 |
0.49 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
60 |
0.46 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
16 |
0.50 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
9 |
0.51 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.18 |
2.94 |
-9.07 |
0 |
4 |
0 |
36 |
300.354 |
6 |
↓
|
|
|
Analogs
-
574908
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
5800 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.17 |
5.36 |
-9.37 |
1 |
4 |
0 |
51 |
281.311 |
3 |
↓
|
|
|
Analogs
-
14824781
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
670 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.64 |
1.93 |
-48.68 |
1 |
5 |
1 |
41 |
394.491 |
4 |
↓
|
|
|
Analogs
-
4098809
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
670 |
0.30 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
3100 |
0.27 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.64 |
10.49 |
-48.7 |
1 |
5 |
1 |
41 |
394.491 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
8750 |
0.59 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.45 |
1.89 |
-4.7 |
2 |
2 |
0 |
40 |
425.696 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 28 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ALDR-4-E |
Aldose Reductase (cluster #4 Of 5), Eukaryotic |
Eukaryotes |
500 |
0.23 |
Binding ≤ 10μM
|
B2CL1-1-E |
Apoptosis Regulator Bcl-X (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
540 |
0.23 |
Binding ≤ 10μM
|
BAD-1-E |
Bcl2-antagonist Of Cell Death (BAD) (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1710 |
0.21 |
Binding ≤ 10μM
|
BCL2-1-E |
Apoptosis Regulator Bcl-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
500 |
0.23 |
Binding ≤ 10μM
|
MCL1-1-E |
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6543 |
0.19 |
Binding ≤ 10μM
|
MDHC-1-E |
Malate Dehydrogenase Cytoplasmic (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5800 |
0.19 |
Binding ≤ 10μM
|
MDHM-2-E |
Malate Dehydrogenase, Mitochondrial (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2800 |
0.20 |
Binding ≤ 10μM
|
Q0PJ46-1-E |
Lactate Dehydrogenase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2640 |
0.21 |
Binding ≤ 10μM
|
Q6VVP7-1-E |
Malate Dehydrogenase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2030 |
0.21 |
Binding ≤ 10μM
|
Z100733-1-O |
CT26 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2210 |
0.21 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
7000 |
0.19 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
9140 |
0.19 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
8400 |
0.19 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
1320 |
0.22 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
3330 |
0.20 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
3700 |
0.20 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.57 |
5.14 |
-19.48 |
6 |
8 |
0 |
156 |
518.562 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
6.57 |
6.21 |
-32.82 |
5 |
8 |
0 |
158 |
517.554 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
3900 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.29 |
-0.04 |
-9.07 |
1 |
2 |
0 |
32 |
271.319 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 25 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1700 |
0.35 |
Binding ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1700 |
0.35 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Binding ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.46 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.34 |
Binding ≤ 10μM |
Q25270-2-E |
Beta Tubulin (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2000 |
0.35 |
Functional ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Functional ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4920 |
0.32 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
TBB3-3-E |
Tubulin Beta-3 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB4A-3-E |
Tubulin Beta-4 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB4B-3-E |
Tubulin Beta-2 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB8-3-E |
Tubulin Beta-8 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
Z100495-1-O |
BMEC (Brain Microvessel Endothelial Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z100742-1-O |
MeWo (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
188 |
0.41 |
Functional ≤ 10μM |
Z103208-1-O |
AU565 (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z103407-2-O |
SW1990 (cluster #2 Of 2), Other |
Other |
250 |
0.40 |
Functional ≤ 10μM
|
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
2000 |
0.35 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
18 |
0.47 |
Functional ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80013-2-O |
A10 (cluster #2 Of 2), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80035-5-O |
B16 (Melanoma Cells) (cluster #5 Of 7), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80064-4-O |
CCRF-CEM (T-cell Leukemia) (cluster #4 Of 9), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80071-2-O |
CEM-0 (T-cell Leukemia) (cluster #2 Of 2), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80099-3-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
2756 |
0.34 |
Functional ≤ 10μM
|
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
36 |
0.45 |
Functional ≤ 10μM
|
Z80121-1-O |
DMS-79 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
124 |
0.42 |
Functional ≤ 10μM
|
Z80125-9-O |
DU-145 (Prostate Carcinoma) (cluster #9 Of 9), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80136-2-O |
FM3A (Breast Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
42 |
0.45 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
94 |
0.43 |
Functional ≤ 10μM |
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM |
Z80193-1-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #1 Of 12), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80229-1-O |
MCF7-DOX (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
13 |
0.48 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
82 |
0.43 |
Functional ≤ 10μM
|
Z80284-3-O |
MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
16 |
0.47 |
Functional ≤ 10μM
|
Z80353-1-O |
OVCAR (cluster #1 Of 1), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
5400 |
0.32 |
Functional ≤ 10μM
|
Z80471-3-O |
SH-SY5 (Bone Marrow Neuroblastoma Cells) (cluster #3 Of 3), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z80485-3-O |
SK-MEL-28 (Melanoma Cells) (cluster #3 Of 6), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM |
Z80555-1-O |
TSGH (cluster #1 Of 1), Other |
Other |
45 |
0.45 |
Functional ≤ 10μM
|
Z80682-7-O |
A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80697-3-O |
Bel-7402 (Hepatoma Cells) (cluster #3 Of 3), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80792-1-O |
Colon 26 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80798-1-O |
CPT30 Cell Line (cluster #1 Of 1), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z80847-3-O |
FaDu (Pharyngeal Carcinoma Cells) (cluster #3 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80852-2-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80874-2-O |
CEM (T-cell Leukemia) (cluster #2 Of 7), Other |
Other |
12 |
0.48 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80900-1-O |
HA22T Cell Line (cluster #1 Of 1), Other |
Other |
2708 |
0.34 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z80967-2-O |
Hone-1 Cell Line (cluster #2 Of 2), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z81001-1-O |
TSGH 9201 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
38 |
0.45 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z81065-3-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z81233-2-O |
M21 (Melanoma Cells) (cluster #2 Of 2), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM |
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z81252-7-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #7 Of 11), Other |
Other |
43 |
0.45 |
Functional ≤ 10μM |
Z81331-6-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #6 Of 6), Other |
Other |
23 |
0.46 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z100495-1-O |
BMEC (Brain Microvessel Endothelial Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
ADME/T ≤ 10μM
|
Z80013-2-O |
A10 (cluster #2 Of 2), Other |
Other |
23 |
0.46 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.52 |
ADME/T ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
0 |
0.00 |
ADME/T ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 4), Other |
Other |
2 |
0.53 |
ADME/T ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
0 |
0.00 |
ADME/T ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 5), Other |
Other |
5 |
0.51 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3 |
0.52 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.47 |
5.32 |
-10.67 |
1 |
5 |
0 |
57 |
316.353 |
6 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
5 |
0.53 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
530 |
0.40 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.18 |
7.8 |
-10.38 |
0 |
4 |
0 |
37 |
300.354 |
6 |
↓
|
|
|
Analogs
-
6897880
-
-
7744413
-
-
8322716
-
-
8322769
-
-
4958293
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
620 |
0.35 |
Binding ≤ 10μM
|
Z103202-2-O |
8505C (cluster #2 Of 2), Other |
Other |
50 |
0.41 |
Functional ≤ 10μM
|
Z103204-1-O |
A427 (cluster #1 Of 4), Other |
Other |
51 |
0.41 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
15 |
0.44 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
2600 |
0.31 |
Functional ≤ 10μM
|
Z80186-2-O |
K562 (Erythroleukemia Cells) (cluster #2 Of 11), Other |
Other |
4 |
0.47 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
22 |
0.43 |
Functional ≤ 10μM
|
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
17 |
0.44 |
Functional ≤ 10μM
|
Z80526-2-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #2 Of 6), Other |
Other |
102 |
0.39 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
68 |
0.40 |
Functional ≤ 10μM
|
Z80847-3-O |
FaDu (Pharyngeal Carcinoma Cells) (cluster #3 Of 3), Other |
Other |
41 |
0.41 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
25 |
0.43 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
16 |
0.44 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
17 |
0.44 |
Functional ≤ 10μM
|
Z80186-2-O |
K562 (Erythroleukemia Cells) (cluster #2 Of 3), Other |
Other |
4 |
0.47 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.78 |
1.46 |
-14.7 |
1 |
6 |
0 |
74 |
344.363 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80491-1-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #1 Of 4), Other |
Other |
2880 |
0.37 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
1580 |
0.39 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.30 |
-0.14 |
-11.75 |
1 |
4 |
0 |
54 |
278.311 |
3 |
↓
|
|
|
Analogs
-
34583707
-
-
39283830
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
1190 |
0.55 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
2340 |
0.53 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.51 |
2.82 |
-9.44 |
2 |
4 |
0 |
75 |
204.181 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
RARA-1-E |
Retinoic Acid Receptor Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.24 |
Binding ≤ 10μM
|
RARB-1-E |
Retinoic Acid Receptor Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2480 |
0.26 |
Binding ≤ 10μM
|
RARG-1-E |
Retinoic Acid Receptor Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
77 |
0.33 |
Binding ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
280 |
0.31 |
Functional ≤ 10μM
|
Z80135-1-O |
F9 (cluster #1 Of 1), Other |
Other |
33 |
0.35 |
Functional ≤ 10μM
|
Z80140-1-O |
GBM (cluster #1 Of 1), Other |
Other |
550 |
0.29 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
490 |
0.29 |
Functional ≤ 10μM
|
Z80250-1-O |
Me665/2/21 (cluster #1 Of 1), Other |
Other |
420 |
0.30 |
Functional ≤ 10μM
|
Z80306-1-O |
NB-4 (Promyelocytic Leukemia Cells) (cluster #1 Of 1), Other |
Other |
400 |
0.30 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
130 |
0.32 |
Functional ≤ 10μM |
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
430 |
0.30 |
Functional ≤ 10μM
|
Z80449-1-O |
SAOS-2 (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
670 |
0.29 |
Functional ≤ 10μM
|
Z80561-1-O |
U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
440 |
0.30 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
510 |
0.29 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
680 |
0.29 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
430 |
0.30 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
350 |
0.30 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
320 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
7.63 |
13.65 |
-51.5 |
1 |
3 |
-1 |
60 |
397.494 |
3 |
↓
|
|
|
Analogs
-
4621972
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.02 |
9.71 |
-12.42 |
0 |
4 |
0 |
41 |
321.376 |
5 |
↓
|
Lo
Low (pH 4.5-6)
|
4.02 |
9.74 |
-30.59 |
1 |
4 |
1 |
42 |
322.384 |
5 |
↓
|
|
|
Analogs
-
7586807
-
-
13137527
-
-
16980597
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 6 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.02 |
9.14 |
-12.54 |
0 |
4 |
0 |
41 |
321.376 |
5 |
↓
|
Lo
Low (pH 4.5-6)
|
4.02 |
9.45 |
-37.78 |
1 |
4 |
1 |
42 |
322.384 |
5 |
↓
|
|
|
Analogs
-
34384993
-
-
585159
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
4640 |
0.26 |
Binding ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
300 |
0.31 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
1280 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.53 |
5.23 |
-13.49 |
3 |
7 |
0 |
100 |
387.395 |
4 |
↓
|
|
|
Analogs
-
32120145
-
-
4100768
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
6500 |
0.35 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
6200 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.53 |
2.88 |
-11.47 |
0 |
3 |
0 |
35 |
302.757 |
5 |
↓
|
|